Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents, and a pioneer in automated nanoliter-scale immunoassays, today announced the launch of three service offerings ...

Expansion leverages proprietary chromatography expertise to overcome purification bottlenecks and secure domestic API manufacturing capacity SK pharmteco, a global contract development and ...

The research agreement enhances Zealand Pharma’s ability to use ‘Big Data’, artificial intelligence and machine learning in the discovery and development of next generation peptide therapeutics From ...

Drug development and production rely on stringent quality controls, reproducibility, and verification. Biopharmaceuticals, including protein-based therapies, require extensive characterization, ...

Scientists have developed stable orally available cyclic peptides with a much higher bioavailability than current ones, virtually creating a generation of drugs that can target previously untreatable ...

For decades, a substantial number of proteins, vital for treating various diseases, have remained elusive to oral drug therapy. Traditional small molecules often struggle to bind to proteins with flat ...

There has been a recent revival in interest in peptide therapeutic development, with five of the top-selling drugs being peptides or proteins (Enbrel, Remicade, Humira, Avastin, MabThera) and many ...

NORFOLK, England--(BUSINESS WIRE)--μLOT® is an entirely new approach to manufacturing therapeutic peptides, which promises to completely replace traditional large-scale batch manufacturing. The µLOT® ...

An analysis of launched peptide drugs and compounds in late-stage development indicated that the peptide market would grow in 2006 at a rate of approximately 5%. Beginning in late 2007, Phase III and ...